Company Analysis
Sign in

CAMP4 Therapeutics Corporation (CAMP)

Nasdaq: CAMP · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 2018
Full chart Alerts Compare
Grade5.1
◀ Past 5.4● Present 4.0▶ Future 6.0
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

4 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to CAMP4 Therapeutics Corporation’s names, not what it holds today.

Patents granted
4
4 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and 1 in 2023
Applications published
18
5 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals3
Biotechnology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Camp4 Therapeutics Corporation its own name
named as the applicant on its applications, in US
0 granted
18 published
CAMP4 Therapeutics Corporation its own name
US, as the owner printed on each patent
4 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jun 3, 202512,319,916Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAsBiotechnologyCAMP4 Therapeutics Corporation
Nov 19, 202412,145,963Phenothiazine derivatives and uses thereofPharmaceuticalsCAMP4 Therapeutics Corporation
Jan 3, 202311,542,290Phenothiazine derivatives and uses thereofPharmaceuticalsCAMP4 Therapeutics Corporation
Mar 8, 202211,266,655Methods and compositions for treating urea cycle disordersPharmaceuticalsCAMP4 Therapeutics Corporation
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 16, 20252025/0320496MODULATION OF ABCB11 GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNASBiotechnologyCamp4 Therapeutics Corporation
Sep 18, 20252025/0290072MODULATION OF SYNGAP1 GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNASBiotechnologyCamp4 Therapeutics Corporation
Aug 7, 20252025/0250575MODULATION OF GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNASBiotechnologyCamp4 Therapeutics Corporation
Jul 31, 20252025/0243488METHODS OF MODULATING PROGRANULIN EXPRESSION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNASPharmaceuticalsCamp4 Therapeutics Corporation
Jan 30, 20252025/0034193PHENOTHIAZINE DERIVATIVES AND USES THEREOFPharmaceuticalsCamp4 Therapeutics Corporation
Oct 31, 20242024/0360451MODULATION OF GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNASBiotechnologyCamp4 Therapeutics Corporation
Oct 10, 20242024/0336924MODULATION OF GENE TRANSCRIPTION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNASBiotechnologyCamp4 Therapeutics Corporation · patent 12,319,916 granted from it
Sep 7, 20232023/0282314CHARACTERIZING FUNCTIONAL REGULATORY ELEMENTS USING MACHINE LEARNINGComputer technologyCamp4 Therapeutics Corporation
Aug 17, 20232023/0257410PHENOTHIAZINE DERIVATIVES AND USES THEREOFPharmaceuticalsCamp4 Therapeutics Corporation · patent 12,145,963 granted from it
Jun 2, 20222022/0168316METHODS AND COMPOSITIONS FOR TREATING UREA CYCLE DISORDERSPharmaceuticalsCamp4 Therapeutics Corporation
What it applied for, 2024 to 2025: Biotechnology 5 · Pharmaceuticals 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton CAMP · research, not advice